Takeda Pharmaceutical Company Limited Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset
Takeda Pharmaceutical Company Limited (TAK) reported Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset of JPY 22.50 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Income Taxes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset · last filed 2025-06-25
| Period end | Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset 12 month | Increase Decrease Through Net Exchange Differences Deferred Tax Liability Asset 12 month as first filed |
|---|---|---|
| 2025-03-31 | 22.50B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | -8.07B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 15.76B JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 30.19B JPY 20-F · filed 2023-06-28 | 30.19B JPY 20-F · filed 2022-06-29 |
| 2021-03-31 | -36.78B JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 129.13B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 27.78B JPY 20-F · filed 2020-06-24 | 27.78B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 650.00M JPY 20-F · filed 2019-06-27 |